Biomarkers of Tumor Metastasis and Invasiveness.
Daniel L Pouliquen1, Cristina Núñez González2
1Inserm, CRCI2NA, CNRS, Université d'Angers, Nantes Université, F-49000 Angers, France.
Cancers
|October 28, 2023
Summary
Researchers are exploring proteins as novel biomarkers for cancer diagnosis and prognosis. Identifying these protein biomarkers is crucial for understanding cancer invasion and metastasis.
Area of Science:
- Oncology
- Biomarker Discovery
- Molecular Diagnostics
Background:
- Proteins are increasingly recognized as valuable tools in oncology.
- Their role in cancer progression, particularly invasion and metastasis, is a key research focus.
Related Concept Videos
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


